Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
<p>Statistics from DESeq2</p>
Na minha lista:
Registos relacionados
-
Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Por: Alyssa C. Flint (16676029)
Publicado em: (2025) -
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Por: Elizabeth R. Tucker (15053624)
Publicado em: (2025) -
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Por: Elizabeth R. Tucker (15053624)
Publicado em: (2025) -
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Por: Elizabeth R. Tucker (15053624)
Publicado em: (2025) -
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Por: Elizabeth R. Tucker (15053624)
Publicado em: (2025)